aspirin has been researched along with Acute Symptom Flare in 5 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin users had a lower incidence rate of total AECOPD (adjusted incidence rate ratio [IRR], 0." | 1.51 | Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study. ( Aaron, CP; Barr, RG; Bowler, RP; Comellas, AP; Cooper, CB; Dransfield, MT; Fawzy, A; Han, MK; Hansel, NN; Hoffman, EA; Kanner, RE; Krishnan, JA; Labaki, WW; Paine, R; Paulin, LM; Peters, SP; Putcha, N; Wise, R, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameli, P | 1 |
| D'Alessandro, M | 1 |
| Bergantini, L | 1 |
| Silvestri, E | 1 |
| Romaldi, A | 1 |
| Emmi, G | 1 |
| Parronchi, P | 1 |
| Bargagli, E | 1 |
| Chavatza, K | 1 |
| Kostopoulou, M | 1 |
| Nikolopoulos, D | 1 |
| Gioti, O | 1 |
| Togia, K | 1 |
| Andreoli, L | 1 |
| Aringer, M | 1 |
| Boletis, J | 1 |
| Doria, A | 1 |
| Houssiau, FA | 1 |
| Jayne, D | 1 |
| Mosca, M | 1 |
| Svenungsson, E | 1 |
| Tincani, A | 1 |
| Bertsias, G | 1 |
| Fanouriakis, A | 1 |
| Boumpas, DT | 1 |
| Li, X | 1 |
| Shopit, A | 1 |
| Wang, J | 1 |
| Fawzy, A | 1 |
| Putcha, N | 1 |
| Aaron, CP | 1 |
| Bowler, RP | 1 |
| Comellas, AP | 1 |
| Cooper, CB | 1 |
| Dransfield, MT | 1 |
| Han, MK | 1 |
| Hoffman, EA | 1 |
| Kanner, RE | 1 |
| Krishnan, JA | 1 |
| Labaki, WW | 1 |
| Paine, R | 1 |
| Paulin, LM | 1 |
| Peters, SP | 1 |
| Wise, R | 1 |
| Barr, RG | 1 |
| Hansel, NN | 1 |
| Tyrak, KE | 1 |
| Kupryś-Lipińska, I | 1 |
| Czarnobilska, E | 1 |
| Jakieła, B | 1 |
| Pajdzik, K | 1 |
| Ćmiel, A | 1 |
| Plutecka, H | 1 |
| Koziej, M | 1 |
| Gawrońska, A | 1 |
| Konduracka, E | 1 |
| Kuna, P | 1 |
| Sanak, M | 1 |
| Mastalerz, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Subpopulations and Intermediate Outcome Measures in COPD Study[NCT01969344] | 2,981 participants (Actual) | Observational | 2010-11-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for aspirin and Acute Symptom Flare
| Article | Year |
|---|---|
Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Ne | 2021 |
4 other studies available for aspirin and Acute Symptom Flare
| Article | Year |
|---|---|
A multicenter approach to evaluate omalizumab effectiveness in Samter's triad.
Topics: Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Asthma | 2020 |
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antirheumatic Agents; Aspirin; Drug Tapering; Europe; Fema | 2021 |
Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.
Topics: Anti-Bacterial Agents; Aspirin; Correlation of Data; Female; Glucocorticoids; Humans; Male; Middle A | 2019 |
Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Biomarkers; Carrier Proteins; | 2019 |